Company / Working Capital
IDEAYA Biosciences, Inc. Working Capital History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$607.9M
FY2025
5-year range
$205.8M / $643.6M
FY2021-FY2025
Trend
-5.6%
vs FY2024
Sector context
#75 of 213
Health Care
What the data says
At $608M, IDEAYA Biosciences, Inc.'s working capital ranks #75 of 213 in the Health Care sector. Working Capital has fluctuated over the past 8 years, ranging from $85M in FY2018 to $644M in FY2024.
Based on SEC 10-K filings.
$608M in FY2025 with a 5-year CAGR of +19.5%.
Improved from $506M to $608M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +21.5%
- 5-Year CAGR
- +19.5%
- 10-Year CAGR
- -
Sector benchmark
#75 of 213 in Health CareTop 35% of 213This company $607.9M Sector average $934.6M
▼
-35.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +19.5%, indicating consistent growth.
- In FY2025, working capital decreased 5.6% year-over-year.
- Ranks #75 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $607.9M | -5.6% |
| FY2024 | $643.6M | +27.3% |
| FY2023 | $505.5M | +49.2% |
| FY2022 | $338.7M | +64.6% |
| FY2021 | $205.8M | -17.7% |
| FY2020 | $250.0M | +163.9% |
| FY2019 | $94.7M | +11.1% |
| FY2018 | $85.3M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026